Generic Antara

The first patent for brand-name Antara expires in 2020. Until an approved generic Antara is released on the market, do not purchase any so-called generic versions of this drug, because you don't know what you're getting.

 

Generic Antara: An Overview

Antara™ (fenofibrate) is a prescription medication that has been licensed to treat several conditions. These Antara uses include:
 
Antara is manufactured by Oscient Pharmaceuticals Corporation and is currently protected by a patent that prevents any generic Antara from being manufactured.
 
If you search the Internet for "generic Antara," however, you will find a number of companies selling it. The fact is that these medicines could be fake, substandard, and potentially dangerous. You should not buy any generic Antara until there is an approved version available.
 

When Will There Be a Generic Antara?

The first patent for Antara currently expires in August 2020.
 This is the earliest predictable date that a generic version of Antara could become available.
 
However, there are other circumstances that could come up to extend or shorten the exclusivity period of Antara. This could include such things as lawsuits or other patents for specific Antara uses. Once Antara goes off patent, there may be several companies that manufacture a generic Antara drug.
  
Generic Antara Article Continues on Next Page >
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD
 
Other Articles in This eMedTV Presentation
Referring Pages Articles